Well, I would expect to have an explanation about why the expectation of an announcement in a few weeks is delayed. This management has a long history of fuzzy information. That is why it is hard to trust what they say. That’s why the FDA doesn’t, compared to competitors.
Im not saying incorrect information is provided, just that there is an absence of full and frank information. So, the market is left to speculate. A lot.
Very poor form that.
Where is Novartis?, page-1138
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |